The smallpox treatment market — encompassing antiviral drugs and vaccines maintained specifically for biodefense preparedness against a disease naturally eradicated worldwide since 1980 — represents one of pharmaceutical medicine's most unusual commercial categories, operating on a model driven entirely by national security and government stockpiling rather than any actual ongoing...